Athira Pharma to Present Additional Biomarker Data from ACT-AD Phase 2 Study of Fosgonimeton at … – The Bakersfield Californian

Athira Pharma to Present Additional Biomarker Data from ACT-AD Phase 2 Study of Fosgonimeton at … – The Bakersfield Californian
Source: Google NewsPublished on 2022-11-21